Last reviewed · How we verify
Kangdaprevir Sodium Tablet
At a glance
| Generic name | Kangdaprevir Sodium Tablet |
|---|---|
| Also known as | HEC84048Na |
| Sponsor | Sunshine Lake Pharma Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- The Tolerability and Pharmacokinetics Study of Kangdaprevir Sodium Tablet in Healthy Adult Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Kangdaprevir Sodium Tablet CI brief — competitive landscape report
- Kangdaprevir Sodium Tablet updates RSS · CI watch RSS
- Sunshine Lake Pharma Co., Ltd. portfolio CI